IRIS Accounts Production v25.4.0.155 07844859 director 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078448592024-03-31078448592025-03-31078448592024-04-012025-03-31078448592023-03-31078448592023-04-012024-03-31078448592024-03-3107844859ns15:EnglandWales2024-04-012025-03-3107844859ns14:PoundSterling2024-04-012025-03-3107844859ns10:Director12024-04-012025-03-3107844859ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107844859ns10:SmallEntities2024-04-012025-03-3107844859ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107844859ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107844859ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107844859ns10:FullAccounts2024-04-012025-03-3107844859ns10:OrdinaryShareClass12024-04-012025-03-3107844859ns10:RegisteredOffice2024-04-012025-03-3107844859ns5:CurrentFinancialInstruments2025-03-3107844859ns5:CurrentFinancialInstruments2024-03-3107844859ns5:Non-currentFinancialInstruments2025-03-3107844859ns5:Non-currentFinancialInstruments2024-03-3107844859ns5:ShareCapital2025-03-3107844859ns5:ShareCapital2024-03-3107844859ns5:RetainedEarningsAccumulatedLosses2025-03-3107844859ns5:RetainedEarningsAccumulatedLosses2024-03-3107844859ns5:FurnitureFittings2024-04-012025-03-3107844859ns5:MotorVehicles2024-04-012025-03-3107844859ns5:ComputerEquipment2024-04-012025-03-3107844859ns5:ShortLeaseholdAssetsns5:LandBuildings2024-03-3107844859ns5:FurnitureFittings2024-03-3107844859ns5:MotorVehicles2024-03-3107844859ns5:ComputerEquipment2024-03-3107844859ns5:ShortLeaseholdAssetsns5:LandBuildings2024-04-012025-03-3107844859ns5:ShortLeaseholdAssetsns5:LandBuildings2025-03-3107844859ns5:FurnitureFittings2025-03-3107844859ns5:MotorVehicles2025-03-3107844859ns5:ComputerEquipment2025-03-3107844859ns5:ShortLeaseholdAssetsns5:LandBuildings2024-03-3107844859ns5:FurnitureFittings2024-03-3107844859ns5:MotorVehicles2024-03-3107844859ns5:ComputerEquipment2024-03-3107844859ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107844859ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107844859ns5:DeferredTaxation2024-03-3107844859ns5:DeferredTaxation2024-04-012025-03-3107844859ns5:DeferredTaxation2025-03-3107844859ns10:OrdinaryShareClass12025-03-3107844859ns5:RetainedEarningsAccumulatedLosses2024-03-3107844859ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31
REGISTERED NUMBER: 07844859 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Elmo Medical Writing & Editorial Limited

Elmo Medical Writing & Editorial Limited (Registered number: 07844859)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Elmo Medical Writing & Editorial Limited

Company Information
for the Year Ended 31 March 2025







DIRECTOR: E Davison





REGISTERED OFFICE: Shadwell House
65 Lower Green Road
Rusthall
Tunbridge Wells
Kent
TN4 8TW





REGISTERED NUMBER: 07844859 (England and Wales)





ACCOUNTANTS: Peter Hodgson & Co.
Chartered Accountants
Shadwell House
65 Lower Green Road
Tunbridge Wells
Kent
TN4 8TW

Elmo Medical Writing & Editorial Limited (Registered number: 07844859)

Statement of Financial Position
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 46,693 48,543

CURRENT ASSETS
Debtors 5 12,636 4,824
Cash at bank 77,441 61,634
90,077 66,458
CREDITORS
Amounts falling due within one year 6 8,846 3,551
NET CURRENT ASSETS 81,231 62,907
TOTAL ASSETS LESS CURRENT
LIABILITIES

127,924

111,450

CREDITORS
Amounts falling due after more than one
year

7

(40

)

(4,088

)

PROVISIONS FOR LIABILITIES 8 (6,433 ) (2,778 )
NET ASSETS 121,451 104,584

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 10 121,449 104,582
SHAREHOLDERS' FUNDS 121,451 104,584

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Elmo Medical Writing & Editorial Limited (Registered number: 07844859)

Statement of Financial Position - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5 December 2025 and were signed by:





E Davison - Director


Elmo Medical Writing & Editorial Limited (Registered number: 07844859)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Elmo Medical Writing & Editorial Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
There are no significant judgments or estimates pertaining to these accounts.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Motor vehicles - Straight line over 8 years
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Functional currency
The company's functional currency is £ Sterling.

Financial instruments
Basic financial instruments comprising debtors, bank and cash balances are recorded at fair value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

Elmo Medical Writing & Editorial Limited (Registered number: 07844859)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. PROPERTY, PLANT AND EQUIPMENT
Fixtures
Short and Motor Computer
leasehold fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 22,984 24,901 50,448 8,503 106,836
Additions - 624 41,200 - 41,824
Disposals - - (50,448 ) - (50,448 )
At 31 March 2025 22,984 25,525 41,200 8,503 98,212
DEPRECIATION
At 1 April 2024 22,984 16,079 12,612 6,618 58,293
Charge for year - 2,362 5,632 472 8,466
Eliminated on disposal - - (15,240 ) - (15,240 )
At 31 March 2025 22,984 18,441 3,004 7,090 51,519
NET BOOK VALUE
At 31 March 2025 - 7,084 38,196 1,413 46,693
At 31 March 2024 - 8,822 37,836 1,885 48,543

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 12,636 2,400
VAT - 2,424
12,636 4,824

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Tax 5,953 1,751
Social security and other taxes (518 ) -
VAT 1,707 -
Accrued expenses 1,704 1,800
8,846 3,551

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Directors' loan accounts 40 4,088

8. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 6,433 2,778

Elmo Medical Writing & Editorial Limited (Registered number: 07844859)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 April 2024 2,778
Provided during year 3,655
Balance at 31 March 2025 6,433

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
2 Ordinary £1 2 2

10. RESERVES
Retained
earnings
£   

At 1 April 2024 104,582
Profit for the year 28,897
Dividends (12,030 )
At 31 March 2025 121,449